 | Up a level |
Michel, Christian; Burchert, Andreas; Hochhaus, Andreas; Saussele, Susanne; Neubauer, Andreas; Lauseker, Michael; Krause, Stefan W; Kolb, Hans-Jochem; Hossfeld, Dieter Kurt; Nerl, Christoph; Baerlocher, Gabriela M.; Heim, Dominik; Brümmendorf, Tim H; Fabarius, Alice; Haferlach, Claudia; Schlegelberger, Brigitte; Balleisen, Leopold; Goebeler, Maria-Elisabeth; Hänel, Mathias; Ho, Anthony; ... (2019). Imatinib dose reduction in major molecular response of chronic myeloid leukemia: results from the German Chronic Myeloid Leukemia-Study IV. Haematologica - the hematology journal, 104(5), pp. 955-962. Ferrata-Storti Foundation 10.3324/haematol.2018.206797
Proetel, Ulrike; Pletsch, Nadine; Lauseker, Michael; Müller, Martin C; Hanfstein, Benjamin; Krause, Stefan W; Kalmanti, Lida; Schreiber, Annette; Heim, Dominik; Baerlocher, Gabriela M.; Hofmann, Wolf-Karsten; Lange, Elisabeth; Einsele, Hermann; Wernli, Martin; Kremers, Stephan; Schlag, Rudolf; Müller, Lothar; Hänel, Mathias; Link, Hartmut; Hertenstein, Bernd; ... (2014). Older patients with chronic myeloid leukemia (≥65 years) profit more from higher imatinib doses than younger patients: a subanalysis of the randomized CML-Study IV. Annals of hematology, 93(7), pp. 1167-1176. Springer 10.1007/s00277-014-2041-0
Hehlmann, Rüdiger; Berger, Ute; Pfirrmann, Markus; Heimpel, Hermann; Hochhaus, Andreas; Hasford, Joerg; Kolb, Hans-Jochem; Lahaye, Tanja; Maywald, Ole; Reiter, Andreas; Hossfeld, Dieter K; Huber, Christoph; Löffler, Helmut; Pralle, Hans; Queisser, Wolfgang; Tobler, Andreas; Nerl, Christoph; Solenthaler, Max; Goebeler, Mariele E; Griesshammer, Martin; ... (2007). Drug treatment is superior to allografting as first-line therapy in chronic myeloid leukemia. Blood, 109(11), pp. 4686-92. Washington, D.C.: American Society of Hematology 10.1182/blood-2006-11-055186
